Prescient Therapeutics Statistics

Total Valuation

ASX:PTX has a market cap or net worth of AUD 57.83 million. The enterprise value is 48.34 million.

Market Cap	57.83M
Enterprise Value	48.34M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:PTX has 1.05 billion shares outstanding. The number of shares has increased by 12.27% in one year.

Current Share Class	1.05B
Shares Outstanding	1.05B
Shares Change (YoY)	+12.27%
Shares Change (QoQ)	+24.55%
Owned by Insiders (%)	9.50%
Owned by Institutions (%)	1.05%
Float	928.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.56
PB Ratio	3.41
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.46
EV / Sales	11.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.95, with a Debt / Equity ratio of 0.02.

Current Ratio	12.95
Quick Ratio	12.10
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.33% and return on invested capital (ROIC) is -33.81%.

Return on Equity (ROE)	-54.33%
Return on Assets (ROA)	-31.75%
Return on Invested Capital (ROIC)	-33.81%
Return on Capital Employed (ROCE)	-51.77%
Weighted Average Cost of Capital (WACC)	5.29%
Revenue Per Employee	1.42M
Profits Per Employee	-2.95M
Employee Count	3
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.95% in the last 52 weeks. The beta is 0.19, so ASX:PTX's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+30.95%
50-Day Moving Average	0.07
200-Day Moving Average	0.06
Relative Strength Index (RSI)	35.27
Average Volume (20 Days)	1,339,393

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PTX had revenue of AUD 4.27 million and -8.86 million in losses. Loss per share was -0.01.

Revenue	4.27M
Gross Profit	4.27M
Operating Income	-8.91M
Pretax Income	-8.86M
Net Income	-8.86M
EBITDA	n/a
EBIT	-8.91M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 9.77 million in cash and 272,915 in debt, giving a net cash position of 9.50 million or 0.01 per share.

Cash & Cash Equivalents	9.77M
Total Debt	272,915
Net Cash	9.50M
Net Cash Per Share	0.01
Equity (Book Value)	16.97M
Book Value Per Share	0.02
Working Capital	15.28M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -208.79% and -207.71%.

Gross Margin	100.00%
Operating Margin	-208.79%
Pretax Margin	-207.71%
Profit Margin	-207.71%
EBITDA Margin	n/a
EBIT Margin	-208.79%
FCF Margin	n/a

Dividends & Yields

ASX:PTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.27%
Shareholder Yield	-12.27%
Earnings Yield	-15.32%
FCF Yield	n/a

Stock Splits

The last stock split was on December 2, 2014. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 2, 2014
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:PTX has an Altman Z-Score of 11.16 and a Piotroski F-Score of 2.

Altman Z-Score	11.16
Piotroski F-Score	2